{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,18]],"date-time":"2026-11-18T07:44:27Z","timestamp":1794987867730,"version":"4.9.1"},"reference-count":94,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Progress in Biophysics and Molecular Biology"],"published-print":{"date-parts":[[2023,7]]},"DOI":"10.1016\/j.pbiomolbio.2023.04.006","type":"journal-article","created":{"date-parts":[[2023,4,18]],"date-time":"2023-04-18T03:59:30Z","timestamp":1681790370000},"page":"19-27","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":17,"special_numbering":"C","title":["From traditional medicine to modern oncology: Scutellarin, a promising natural compound in cancer treatment"],"prefix":"10.1016","volume":"180-181","author":[{"given":"Shadi","family":"Vesaghhamedani","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seyedeh Shabnam","family":"Mazloumi Kiapey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arezoo","family":"Gowhari Shabgah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sedigheh","family":"Amiresmaili","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abbas","family":"Jahanara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maziar","family":"Oveisee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aliakbar","family":"Shekarchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seyed Mohammad","family":"Gheibihayat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Farhad","family":"Jadidi-Niaragh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3073-5302","authenticated-orcid":false,"given":"Jamshid","family":"Gholizadeh Navashenaq","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.pbiomolbio.2023.04.006_bib1","doi-asserted-by":"crossref","first-page":"4565","DOI":"10.1182\/blood-2011-09-380006","article-title":"Blocking ephrinB2 with highly specific antibodies inhibits angiogenesis, lymphangiogenesis, and tumor growth","volume":"119","author":"Ab\u00e9ngozar","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.pbiomolbio.2023.04.006_bib2","series-title":"Medicinal Chemistry of Anticancer Drugs","first-page":"1","article-title":"Chapter 1 - general aspects of cancer chemotherapy","author":"Avenda\u00f1o","year":"2015"},{"key":"10.1016\/j.pbiomolbio.2023.04.006_bib3","first-page":"1050","article-title":"Scutellarin exerts anticancer effects on human leukemia cells via induction of Sub-G1 cell cycle arrest, apoptosis and also inhibits migration and invasion by targeting Raf\/MEK\/ERK signalling pathway","volume":"25","author":"Bao","year":"2020","journal-title":"J. Buon"},{"key":"10.1016\/j.pbiomolbio.2023.04.006_bib4","doi-asserted-by":"crossref","first-page":"38022","DOI":"10.18632\/oncotarget.16723","article-title":"Combination therapy in combating cancer","volume":"8","author":"Bayat Mokhtari","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.pbiomolbio.2023.04.006_bib5","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1016\/j.redox.2015.08.013","article-title":"Nitric oxide-mediated sensitization of resistant tumor cells to apoptosis by chemo-immunotherapeutics","volume":"6","author":"Bonavida","year":"2015","journal-title":"Redox Biol."},{"key":"10.1016\/j.pbiomolbio.2023.04.006_bib6","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1038\/nrc.2017.118","article-title":"EMT in cancer","volume":"18","author":"Brabletz","year":"2018","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.pbiomolbio.2023.04.006_bib7","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1111\/1759-7714.12962","article-title":"Scutellarin suppresses proliferation and promotes apoptosis in A549 lung adenocarcinoma cells via AKT\/mTOR\/4EBP1 and STAT3 pathways","volume":"10","author":"Cao","year":"2019","journal-title":"Thorac. Cancer"},{"key":"10.1016\/j.pbiomolbio.2023.04.006_bib8","doi-asserted-by":"crossref","first-page":"869","DOI":"10.2174\/138955705774329564","article-title":"Pharmacological properties of indazole derivatives: recent developments","volume":"5","author":"Cerecetto","year":"2005","journal-title":"Mini Rev. Med. Chem."},{"key":"10.1016\/j.pbiomolbio.2023.04.006_bib9","first-page":"3043","article-title":"Scutellarin sensitizes drug-evoked colon cancer cell apoptosis through enhanced caspase-6 activation","volume":"29","author":"Chan","year":"2009","journal-title":"Anticancer Res."},{"key":"10.1016\/j.pbiomolbio.2023.04.006_bib10","doi-asserted-by":"crossref","DOI":"10.1016\/j.jep.2022.115691","article-title":"Effects of breviscapine on cerebral ischemia-reperfusion injury and intestinal flora imbalance by regulating the TLR4\/MyD88\/NF-\u03baB signaling pathway in rats","volume":"300","author":"Chen","year":"2023","journal-title":"J. Ethnopharmacol."},{"key":"10.1016\/j.pbiomolbio.2023.04.006_bib11","article-title":"Integrated transcript and metabolite profiles reveal that EbCHI plays an important role in scutellarin accumulation in Erigeron breviscapus hairy roots","volume":"9","author":"Chen","year":"2018","journal-title":"Front. Plant Sci."},{"key":"10.1016\/j.pbiomolbio.2023.04.006_bib12","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2022.113187","article-title":"Scutellarin enhances anti-tumor immune responses by reducing TNFR2-expressing CD4+Foxp3+ regulatory T cells","volume":"151","author":"Chen","year":"2022","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.pbiomolbio.2023.04.006_bib13","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.4049\/jimmunol.1202659","article-title":"TNFR2 is critical for the stabilization of the CD4+Foxp3+ regulatory T cell phenotype in the inflammatory environment","volume":"190","author":"Chen","year":"2013","journal-title":"J. Immunol."},{"key":"10.1016\/j.pbiomolbio.2023.04.006_bib14","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1001\/jamaoncol.2021.6987","article-title":"Cancer incidence, mortality, years of life lost, years lived with disability, and disability-adjusted life years for 29 cancer groups from 2010 to 2019: a systematic analysis for the global burden of disease study 2019","volume":"8","author":"Collaboration","year":"2022","journal-title":"JAMA Oncol."},{"key":"10.1016\/j.pbiomolbio.2023.04.006_bib15","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1002\/1097-4636(20001215)52:4<725::AID-JBM18>3.0.CO;2-O","article-title":"Integrin-mediated signaling regulates AP-1 transcription factors and proliferation in osteoblasts","volume":"52","author":"Cowles","year":"2000","journal-title":"J. Biomed. Mater. Res."},{"key":"10.1016\/j.pbiomolbio.2023.04.006_bib16","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1634\/theoncologist.2016-0319","article-title":"A systematic review of strategies to prevent cisplatin\u2010induced nephrotoxicity","volume":"22","author":"Crona","year":"2017","journal-title":"Oncol."},{"key":"10.1016\/j.pbiomolbio.2023.04.006_bib17","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1111\/j.1751-7915.2010.00221.x","article-title":"Natural products for cancer chemotherapy","volume":"4","author":"Demain","year":"2011","journal-title":"Microb. Biotechnol."},{"key":"10.1016\/j.pbiomolbio.2023.04.006_bib18","doi-asserted-by":"crossref","first-page":"1505","DOI":"10.1016\/j.biopha.2018.08.127","article-title":"Scutellarin inhibits human renal cancer cell proliferation and migration via upregulation of PTEN","volume":"107","author":"Deng","year":"2018","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.pbiomolbio.2023.04.006_bib19","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1007\/s00204-012-0821-7","article-title":"Cisplatin-induced nephrotoxicity and targets of nephroprotection: an update","volume":"86","author":"dos Santos","year":"2012","journal-title":"Arch. Toxicol."},{"key":"10.1016\/j.pbiomolbio.2023.04.006_bib20","doi-asserted-by":"crossref","first-page":"2456","DOI":"10.3109\/10428194.2012.693177","article-title":"Novel function of scutellarin in inhibiting cell proliferation and inducing cell apoptosis of human Burkitt lymphoma Namalwa cells","volume":"53","author":"Feng","year":"2012","journal-title":"Leuk. Lymphoma"},{"key":"10.1016\/j.pbiomolbio.2023.04.006_bib21","doi-asserted-by":"crossref","DOI":"10.3390\/genes11070719","article-title":"PTEN alterations and their role in cancer management: are we making headway on precision medicine?","volume":"11","author":"Fusco","year":"2020","journal-title":"Genes"},{"key":"10.1016\/j.pbiomolbio.2023.04.006_bib22","doi-asserted-by":"crossref","first-page":"1491","DOI":"10.3892\/or.2017.5850","article-title":"Cytotoxic and chemosensitization effects of Scutellarin from traditional Chinese herb Scutellaria altissima L. in human prostate cancer cells","volume":"38","author":"Gao","year":"2017","journal-title":"Oncol. Rep."},{"key":"10.1016\/j.pbiomolbio.2023.04.006_bib23","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2017.00289","article-title":"Therapeutic effects of breviscapine in cardiovascular diseases: a review","volume":"8","author":"Gao","year":"2017","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.pbiomolbio.2023.04.006_bib24","doi-asserted-by":"crossref","first-page":"320","DOI":"10.2174\/156800909788166600","article-title":"Overcoming drug resistance by enhancing apoptosis of tumor cells","volume":"9","author":"Gim\u00e9nez-Bonaf\u00e9","year":"2009","journal-title":"Curr. Cancer Drug Targets"},{"key":"10.1016\/j.pbiomolbio.2023.04.006_bib25","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.immuni.2019.06.025","article-title":"Inflammation and cancer: triggers, mechanisms, and consequences","volume":"51","author":"Greten","year":"2019","journal-title":"Immunity"},{"key":"10.1016\/j.pbiomolbio.2023.04.006_bib26","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1038\/386463a0","article-title":"Structure of 20S proteasome from yeast at 2.4 A resolution","volume":"386","author":"Groll","year":"1997","journal-title":"Nature"},{"key":"10.1016\/j.pbiomolbio.2023.04.006_bib27","first-page":"293","article-title":"Cancer chemotherapy: targeting folic acid synthesis","volume":"2","author":"Hagner","year":"2010","journal-title":"Cancer Manag. Res."},{"key":"10.1016\/j.pbiomolbio.2023.04.006_bib28","doi-asserted-by":"crossref","first-page":"8479","DOI":"10.1111\/jcmm.16809","article-title":"EGR1 promoted anticancer effects of Scutellarin via regulating LINC00857\/miR-150-5p\/c-Myc in osteosarcoma","volume":"25","author":"Han","year":"2021","journal-title":"J. Cell Mol. Med."},{"key":"10.1016\/j.pbiomolbio.2023.04.006_bib29","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1007\/s00044-022-02885-z","article-title":"Design, synthesis of amide derivatives of scutellarin and their antileukemia and neuroprotective activities","volume":"31","author":"Han","year":"2022","journal-title":"Med. Chem. Res."},{"key":"10.1016\/j.pbiomolbio.2023.04.006_bib30","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/j.ejmech.2017.03.020","article-title":"Scutellarin derivatives as apoptosis inducers: design, synthesis and biological evaluation","volume":"135","author":"Han","year":"2017","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.pbiomolbio.2023.04.006_bib31","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1007\/s12185-016-2008-0","article-title":"Histone deacetylase inhibitors in multiple myeloma: from bench to bedside","volume":"104","author":"Harada","year":"2016","journal-title":"Int. J. Hematol."},{"key":"10.1016\/j.pbiomolbio.2023.04.006_bib32","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1038\/onc.2016.256","article-title":"Antiangiogenic and tumour inhibitory effects of downregulating tumour endothelial FABP4","volume":"36","author":"Harjes","year":"2017","journal-title":"Oncogene"},{"key":"10.1016\/j.pbiomolbio.2023.04.006_bib33","article-title":"Combined scutellarin and C(18)H(17)NO(6) imperils the survival of glioma: partly associated with the repression of PSEN1\/PI3K-AKT signaling Axis","volume":"11","author":"He","year":"2021","journal-title":"Front. Oncol."},{"key":"10.1016\/j.pbiomolbio.2023.04.006_bib34","doi-asserted-by":"crossref","first-page":"5130","DOI":"10.12659\/MSM.904492","article-title":"Scutellarin inhibits proliferation, invasion, and tumorigenicity in human breast cancer cells by regulating HIPPO-YAP signaling pathway","volume":"23","author":"Hou","year":"2017","journal-title":"Med. Sci. Monit."},{"key":"10.1016\/j.pbiomolbio.2023.04.006_bib35","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.carres.2013.07.009","article-title":"A novel polyrotaxane-based delivery system for scutellarin: preparation, characterization, and in vitro evaluation","volume":"380","author":"Jiang","year":"2013","journal-title":"Carbohydr. Res."},{"key":"10.1016\/j.pbiomolbio.2023.04.006_bib36","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.cellsig.2010.08.012","article-title":"Fibronectin and vitronectin induce AP-1-mediated matrix metalloproteinase-9 expression through integrin \u03b15\u03b21\/\u03b1v\u03b23-dependent Akt, ERK and JNK signaling pathways in human umbilical vein endothelial cells","volume":"23","author":"Jin","year":"2011","journal-title":"Cell. Signal."},{"key":"10.1016\/j.pbiomolbio.2023.04.006_bib37","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/S0168-3659(02)00171-2","article-title":"Cyclodextrin conjugate-based controlled release system: repeated- and prolonged-releases of ketoprofen after oral administration in rats","volume":"82","author":"Kamada","year":"2002","journal-title":"J. Contr. Release"},{"key":"10.1016\/j.pbiomolbio.2023.04.006_bib38","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1016\/j.bbrc.2016.12.114","article-title":"Scutellarin suppresses migration and invasion of human hepatocellular carcinoma by inhibiting the STAT3\/Girdin\/Akt activity","volume":"483","author":"Ke","year":"2017","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.pbiomolbio.2023.04.006_bib39","doi-asserted-by":"crossref","first-page":"2330","DOI":"10.1182\/blood-2005-04-1655","article-title":"The soluble extracellular domain of EphB4 (sEphB4) antagonizes EphB4-EphrinB2 interaction, modulates angiogenesis, and inhibits tumor growth","volume":"107","author":"Kertesz","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.pbiomolbio.2023.04.006_bib40","doi-asserted-by":"crossref","first-page":"415","DOI":"10.5483\/BMBRep.2019.52.7.152","article-title":"Highlighted STAT3 as a potential drug target for cancer therapy","volume":"52","author":"Lee","year":"2019","journal-title":"BMB Rep."},{"key":"10.1016\/j.pbiomolbio.2023.04.006_bib41","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1248\/bpb.b20-00822","article-title":"Scutellarin inhibits the growth and EMT of gastric cancer cells through regulating PTEN\/PI3K pathway","volume":"44","author":"Li","year":"2021","journal-title":"Biol. Pharm. Bull."},{"key":"10.1016\/j.pbiomolbio.2023.04.006_bib42","article-title":"Potentiation of scutellarin on human tongue carcinoma xenograft by low-intensity ultrasound","volume":"8","author":"Li","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.pbiomolbio.2023.04.006_bib43","doi-asserted-by":"crossref","first-page":"1674","DOI":"10.3892\/ijo.2013.1873","article-title":"Scutellarin inhibits the growth and invasion of human tongue squamous carcinoma through the inhibition of matrix metalloproteinase-2 and -9 and \u03b1v\u03b26 integrin","volume":"42","author":"Li","year":"2013","journal-title":"Int. J. Oncol."},{"key":"10.1016\/j.pbiomolbio.2023.04.006_bib44","first-page":"212","article-title":"Scutellarin circumvents chemoresistance, promotes apoptosis, and represses tumor growth by HDAC\/miR-34a-mediated down-modulation of Akt\/mTOR and NF-\u03baB-orchestrated signaling pathways in multiple myeloma","volume":"13","author":"Li","year":"2020","journal-title":"Int. J. Clin. Exp. Pathol."},{"key":"10.1016\/j.pbiomolbio.2023.04.006_bib45","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1007\/s12032-019-1333-6","article-title":"Friend or foe, the role of EGR-1 in cancer","volume":"37","author":"Li","year":"2019","journal-title":"Med. Oncol."},{"key":"10.1016\/j.pbiomolbio.2023.04.006_bib46","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1002\/pat.3477","article-title":"Folic acid-polyamine-\u03b2-cyclodextrin for targeted delivery of scutellarin to cancer cells","volume":"26","author":"Liao","year":"2015","journal-title":"Polym. Adv. Technol."},{"key":"10.1016\/j.pbiomolbio.2023.04.006_bib47","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.tibs.2015.12.001","article-title":"The Warburg effect: how does it benefit cancer cells?","volume":"41","author":"Liberti","year":"2016","journal-title":"Trends Biochem. Sci."},{"key":"10.1016\/j.pbiomolbio.2023.04.006_bib48","doi-asserted-by":"crossref","first-page":"3040","DOI":"10.1111\/jcmm.14169","article-title":"Scutellarin inhibits proliferation and invasion of hepatocellular carcinoma cells via down-regulation of JAK2\/STAT3 pathway","volume":"23","author":"Liu","year":"2019","journal-title":"J. Cell Mol. Med."},{"key":"10.1016\/j.pbiomolbio.2023.04.006_bib49","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1038\/nrc1074","article-title":"5-fluorouracil: mechanisms of action and clinical strategies","volume":"3","author":"Longley","year":"2003","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.pbiomolbio.2023.04.006_bib50","doi-asserted-by":"crossref","first-page":"1745","DOI":"10.1007\/s00018-019-03351-7","article-title":"Tumor angiogenesis: causes, consequences, challenges and opportunities","volume":"77","author":"Lugano","year":"2020","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.pbiomolbio.2023.04.006_bib51","doi-asserted-by":"crossref","first-page":"23169","DOI":"10.1002\/jcp.28883","article-title":"Scutellarin inhibits hypoxia-induced epithelial-mesenchymal transition in bladder cancer cells","volume":"234","author":"Lv","year":"2019","journal-title":"J. Cell. Physiol."},{"key":"10.1016\/j.pbiomolbio.2023.04.006_bib52","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0016234","article-title":"Suppression of osteosarcoma cell invasion by chemotherapy is mediated by urokinase plasminogen activator activity via up-regulation of EGR1","volume":"6","author":"Matsunoshita","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.pbiomolbio.2023.04.006_bib53","doi-asserted-by":"crossref","first-page":"761","DOI":"10.3389\/fonc.2019.00761","article-title":"Proteasomes and several aspects of their heterogeneity relevant to cancer","volume":"9","author":"Morozov","year":"2019","journal-title":"Front. Oncol."},{"key":"10.1016\/j.pbiomolbio.2023.04.006_bib54","doi-asserted-by":"crossref","DOI":"10.1016\/j.biotechadv.2018.11.005","article-title":"Flavonoid biosynthetic pathways in plants: versatile targets for metabolic engineering","volume":"38","author":"Nabavi","year":"2020","journal-title":"Biotechnol. Adv."},{"key":"10.1016\/j.pbiomolbio.2023.04.006_bib55","doi-asserted-by":"crossref","DOI":"10.1016\/j.nano.2020.102150","article-title":"Doxil chemotherapy plus liposomal P5 immunotherapy decreased myeloid-derived suppressor cells in murine model of breast cancer","volume":"24","author":"Navashenaq","year":"2020","journal-title":"Nanomed. Nanotechnol. Biol. Med."},{"key":"10.1016\/j.pbiomolbio.2023.04.006_bib56","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1021\/acs.jnatprod.5b01055","article-title":"Natural products as sources of new drugs from 1981 to 2014","volume":"79","author":"Newman","year":"2016","journal-title":"J. Nat. Prod."},{"key":"10.1016\/j.pbiomolbio.2023.04.006_bib57","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1021\/acs.jnatprod.9b01285","article-title":"Natural products as sources of new drugs over the nearly four decades from 01\/1981 to 09\/2019","volume":"83","author":"Newman","year":"2020","journal-title":"J. Nat. Prod."},{"key":"10.1016\/j.pbiomolbio.2023.04.006_bib58","doi-asserted-by":"crossref","DOI":"10.3390\/molecules23020310","article-title":"Synthesis of scutellarein derivatives with a long aliphatic chain and their biological evaluation against human cancer cells","volume":"23","author":"Ni","year":"2018","journal-title":"Molecules"},{"key":"10.1016\/j.pbiomolbio.2023.04.006_bib59","doi-asserted-by":"crossref","first-page":"14721","DOI":"10.1002\/jcp.28230","article-title":"Targeted-nanoliposomal combretastatin A4 (CA-4) as an efficient antivascular candidate in the metastatic cancer treatment","volume":"234","author":"Nik","year":"2019","journal-title":"J. Cell. Physiol."},{"key":"10.1016\/j.pbiomolbio.2023.04.006_bib60","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/j.jep.2015.02.031","article-title":"Scutellarin protects against the liver injury induced by diosbulbin B in mice and its mechanism","volume":"164","author":"Niu","year":"2015","journal-title":"J. Ethnopharmacol."},{"key":"10.1016\/j.pbiomolbio.2023.04.006_bib61","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2018.00245","article-title":"Editorial: adverse effects of cancer chemotherapy: anything new to improve tolerance and reduce sequelae?","volume":"9","author":"Nurgali","year":"2018","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.pbiomolbio.2023.04.006_bib62","doi-asserted-by":"crossref","first-page":"2080","DOI":"10.1111\/cas.14069","article-title":"Regulatory T (Treg) cells in cancer: can Treg cells be a new therapeutic target?","volume":"110","author":"Ohue","year":"2019","journal-title":"Cancer Sci."},{"key":"10.1016\/j.pbiomolbio.2023.04.006_bib63","doi-asserted-by":"crossref","first-page":"e47","DOI":"10.1017\/jns.2016.41","article-title":"Flavonoids: an overview","volume":"5","author":"Panche","year":"2016","journal-title":"J. Nutr. Sci."},{"key":"10.1016\/j.pbiomolbio.2023.04.006_bib64","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1093\/oxfordjournals.jncimonographs.a003451","article-title":"Side effects of chemotherapy and combined chemohormonal therapy in women with early-stage breast cancer","author":"Partridge","year":"2001","journal-title":"J. Natl. Cancer Inst. Monogr."},{"key":"10.1016\/j.pbiomolbio.2023.04.006_bib65","doi-asserted-by":"crossref","first-page":"961","DOI":"10.3332\/ecancer.2019.961","article-title":"Innovative approaches for cancer treatment: current perspectives and new challenges","volume":"13","author":"Pucci","year":"2019","journal-title":"Ecancermedicalscience"},{"key":"10.1016\/j.pbiomolbio.2023.04.006_bib66","doi-asserted-by":"crossref","DOI":"10.1038\/srep37727","article-title":"The Warburg effect mediator pyruvate kinase M2 expression and regulation in the retina","volume":"6","author":"Rajala","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.pbiomolbio.2023.04.006_bib67","doi-asserted-by":"crossref","first-page":"2977","DOI":"10.1016\/j.bbamcr.2016.09.012","article-title":"Activation of apoptosis signalling pathways by reactive oxygen species","volume":"1863","author":"Redza-Dutordoir","year":"2016","journal-title":"Biochim. Biophys. Acta Mol. Cell Res."},{"key":"10.1016\/j.pbiomolbio.2023.04.006_bib68","volume":"vol. 8","author":"Rodr\u00edguez-Garc\u00eda","year":"2019"},{"key":"10.1016\/j.pbiomolbio.2023.04.006_bib69","doi-asserted-by":"crossref","first-page":"9408","DOI":"10.1200\/JCO.2005.01.5594","article-title":"Targeting the cell cycle: a new approach to cancer therapy","volume":"23","author":"Schwartz","year":"2005","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.pbiomolbio.2023.04.006_bib70","article-title":"Chemokine CXCL14; a double-edged sword in cancer development","volume":"97","author":"Shabgah","year":"2021","journal-title":"Int. Immunopharm."},{"key":"10.1016\/j.pbiomolbio.2023.04.006_bib71","doi-asserted-by":"crossref","DOI":"10.2174\/1389450122666210216091953","article-title":"The role of Non-coding Genome in Cancer-associated Fibroblasts; state-of-the-art and perspectives in cancer targeted therapy","author":"Shabgah","year":"2021","journal-title":"Curr. Drug Targets"},{"key":"10.1016\/j.pbiomolbio.2023.04.006_bib72","article-title":"CXC chemokine ligand 16: a Swiss army knife chemokine in cancer","volume":"23","author":"Shabgah","year":"2021","journal-title":"Expet Rev. Mol. Med."},{"key":"10.1016\/j.pbiomolbio.2023.04.006_bib73","series-title":"Progress in Biophysics and Molecular Biology","article-title":"The role of non-coding genome in the behavior of infiltrated myeloid-derived suppressor cells in tumor microenvironment; a perspective and state-of-the-art in cancer targeted therapy","author":"Shabgah","year":"2020"},{"key":"10.1016\/j.pbiomolbio.2023.04.006_bib74","article-title":"Curcumin and cancer; are long non-coding RNAs missing link?","author":"Shabgah","year":"2021","journal-title":"Prog. Biophys. Mol. Biol."},{"key":"10.1016\/j.pbiomolbio.2023.04.006_bib75","doi-asserted-by":"crossref","first-page":"2109","DOI":"10.1016\/j.biopha.2018.09.024","article-title":"Scutellarein selectively targets multiple myeloma cells by increasing mitochondrial superoxide production and activating intrinsic apoptosis pathway","volume":"109","author":"Shi","year":"2019","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.pbiomolbio.2023.04.006_bib76","first-page":"2425","article-title":"Sonodynamic cancer therapy: a non-invasive and repeatable approach using low-intensity ultrasound with a sonosensitizer","volume":"31","author":"Shibaguchi","year":"2011","journal-title":"Anticancer Res."},{"key":"10.1016\/j.pbiomolbio.2023.04.006_bib77","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2019.108647","article-title":"Renoprotective effect of scutellarin on cisplatin-induced renal injury in mice: impact on inflammation, apoptosis, and autophagy","volume":"112","author":"Sun","year":"2019","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.pbiomolbio.2023.04.006_bib78","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1038\/nrd.2015.1","article-title":"Gasotransmitters in cancer: from pathophysiology to experimental therapy","volume":"15","author":"Szabo","year":"2016","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.pbiomolbio.2023.04.006_bib79","doi-asserted-by":"crossref","first-page":"1743","DOI":"10.1021\/cr970022c","article-title":"Introduction and general overview of cyclodextrin chemistry","volume":"98","author":"Szejtli","year":"1998","journal-title":"Chem. Rev."},{"key":"10.1016\/j.pbiomolbio.2023.04.006_bib80","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1097\/FJC.0000000000000109","article-title":"Scutellarin inhibits high glucose-induced and hypoxia-mimetic agent-induced angiogenic effects in human retinal endothelial cells through reactive oxygen species\/hypoxia-inducible factor-1\u03b1\/vascular endothelial growth factor pathway","volume":"64","author":"Wang","year":"2014","journal-title":"J. Cardiovasc. Pharmacol."},{"key":"10.1016\/j.pbiomolbio.2023.04.006_bib81","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1016\/j.fitote.2011.12.001","article-title":"Antitumor activity of Dioscorea bulbifera L. rhizome in vivo","volume":"83","author":"Wang","year":"2012","journal-title":"Fitoterapia"},{"key":"10.1016\/j.pbiomolbio.2023.04.006_bib82","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.pharmthera.2018.05.006","article-title":"Clinical benefits and pharmacology of scutellarin: a comprehensive review","volume":"190","author":"Wang","year":"2018","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.pbiomolbio.2023.04.006_bib83","doi-asserted-by":"crossref","first-page":"1362","DOI":"10.1002\/ptr.4878","article-title":"Baicalin and scutellarin are proteasome inhibitors that specifically target chymotrypsin-like catalytic activity","volume":"27","author":"Wu","year":"2013","journal-title":"Phytother Res."},{"key":"10.1016\/j.pbiomolbio.2023.04.006_bib84","doi-asserted-by":"crossref","first-page":"1524","DOI":"10.1002\/ptr.4892","article-title":"Scutellarin-induced apoptosis in HepG2 hepatocellular carcinoma cells via a STAT3 pathway","volume":"27","author":"Xu","year":"2013","journal-title":"Phytother Res."},{"key":"10.1016\/j.pbiomolbio.2023.04.006_bib85","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.1016\/j.carbpol.2012.10.012","article-title":"Scutellarin-cyclodextrin conjugates: synthesis, characterization and anticancer activity","volume":"92","author":"Yang","year":"2013","journal-title":"Carbohydr. Polym."},{"key":"10.1016\/j.pbiomolbio.2023.04.006_bib86","doi-asserted-by":"crossref","first-page":"5404","DOI":"10.1016\/j.bmcl.2017.11.011","article-title":"Scutellarin inhibits Hela cell growth and glycolysis by inhibiting the activity of pyruvate kinase M2","volume":"27","author":"You","year":"2017","journal-title":"Bioorg. Med. Chem. Lett"},{"key":"10.1016\/j.pbiomolbio.2023.04.006_bib87","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2021.174253","article-title":"Scutellarin ameliorates colitis-associated colorectal cancer by suppressing Wnt\/\u03b2-catenin signaling cascade","volume":"906","author":"Zeng","year":"2021","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.pbiomolbio.2023.04.006_bib88","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2022.153972","article-title":"Suppression of colitis-associated colorectal cancer by scutellarin through inhibiting Hedgehog signaling pathway activity","volume":"98","author":"Zeng","year":"2022","journal-title":"Phytomedicine"},{"key":"10.1016\/j.pbiomolbio.2023.04.006_bib89","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1515\/biol-2021-0085","article-title":"Scutellarin-induced A549 cell apoptosis depends on activation of the transforming growth factor-\u03b21\/smad2\/ROS\/caspase-3 pathway","volume":"16","author":"Zhang","year":"2021","journal-title":"Open Life Sci."},{"key":"10.1016\/j.pbiomolbio.2023.04.006_bib90","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1016\/j.bbrc.2005.06.166","article-title":"The anti-HIV-1 effect of scutellarin","volume":"334","author":"Zhang","year":"2005","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.pbiomolbio.2023.04.006_bib91","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.jconrel.2010.04.019","article-title":"Hydrophobic pharmaceuticals mediated self-assembly of \u03b2-cyclodextrin containing hydrophilic copolymers: novel chemical responsive nano-vehicles for drug delivery","volume":"145","author":"Zhang","year":"2010","journal-title":"J. Contr. Release"},{"key":"10.1016\/j.pbiomolbio.2023.04.006_bib92","first-page":"5094","article-title":"Scutellarin suppresses human colorectal cancer metastasis and angiogenesis by targeting ephrinb2","volume":"9","author":"Zhu","year":"2017","journal-title":"Am. J. Transl. Res."},{"key":"10.1016\/j.pbiomolbio.2023.04.006_bib93","first-page":"988","article-title":"Advances in sonoporation strategies for cancer","volume":"4","author":"Zolochevska","year":"2012","journal-title":"Front. Biosci."},{"key":"10.1016\/j.pbiomolbio.2023.04.006_bib94","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1186\/s12943-020-01258-7","article-title":"Targeting STAT3 in cancer immunotherapy","volume":"19","author":"Zou","year":"2020","journal-title":"Mol. Cancer"}],"container-title":["Progress in Biophysics and Molecular Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0079610723000408?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0079610723000408?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,24]],"date-time":"2025-09-24T21:53:33Z","timestamp":1758750813000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0079610723000408"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7]]},"references-count":94,"alternative-id":["S0079610723000408"],"URL":"https:\/\/doi.org\/10.1016\/j.pbiomolbio.2023.04.006","relation":{},"ISSN":["0079-6107"],"issn-type":[{"value":"0079-6107","type":"print"}],"subject":[],"published":{"date-parts":[[2023,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"From traditional medicine to modern oncology: Scutellarin, a promising natural compound in cancer treatment","name":"articletitle","label":"Article Title"},{"value":"Progress in Biophysics and Molecular Biology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pbiomolbio.2023.04.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}